The Glasgow-Blatchford scores (GBS) and Rockall scores (RS) are commonly used for stratifying patients with nonvariceal upper gastrointestinal hemorrhage (NVUGIH). Although predictive value of these scoring methods has been extensively validated, their clinical effectiveness remains unclear. The following study evaluated the GBS and RS scoring system with reference to bleeding, needs for further surgery, endoscopic intervention and death, in order to verify their effectiveness and accuracy in clinical application.
Introduction
Non-variceal upper gastrointestinal hemorrhage (NVUGIH) is bleeding of the digestive tract proximal to the ligament of Treitz, that is, bleeding of the pancreatic or bile ducts, and bleeding from the proximal anastomosis after gastrojejunostomy. [1] The incidence of NVUGIH is 20-60/100,000 people, [2] [3] [4] and is particularly high among elderly patients who carry other types of systemic diseases; the mortality rate in these patients is about 7% to 14%. [5] The prognosis of upper gastrointestinal bleeding may vary from mild to life-threatening. [4] Patients with mild bleeding might fully recover without specific clinical treatment, while
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those with severe bleeding may experience severe complication and even death if they do not receive the treatment for the condition. Thus, it is extremely important to classify NVUGIH severity based on patients' clinical profiles.
Over the last decade, the management of upper gastrointestinal hemorrhage and understanding of its stratification risk have become a hot topic among researches. [6] Besides, early diagnosis, as well as accurate stratification of patients with higher mortality risk and risk of re-bleeding, may significantly increase the efficiency of medical treatment since these data can be used by emergency physicians when making final decisions. [7, 8] So far, multiple scoring systems that stratify patients into those with high and low risk have been developed. [9, 10] Nevertheless, the controversies related to risk stratification, role of endoscopic therapy, the needs for further surgery, endoscopic intervention and death still remain. Accordingly, there is no consensus on how to approach such patients. [11] To date, all the existing studies have focused on in-hospital or 30 days mortality.
Glasgow-Blatchford scores (GBS) and complete Rockall scores (CRS) are commonly used for stratifying NVUGIH cases in terms of risk. Thus far, numerous clinical studies have validated their predictive value; yet, their clinical effectiveness remains unclear. In addition, little data are available concerning this critical condition in China. The following study examined the effectiveness and accuracy of GBS and CRS scoring systems in clinical application in Chinese patients.
Methods

Patients
This study was retrospectively conducted at Kunming Medical University and other seven medical centers (Chinese PLA General Hospital, Beijing Tian Tan Hospital, Zhongshan Hospital, Fudan University, Xi'an Central Hospital, First Affiliated Hospital, Nanjing Medical University, First Affiliated Hospital, Zhejiang Chinese Medical University, Zhongshan Hospital, Xiamen University, First People's Hospital of Foshan). The ethics committee from Kunming Medical University approved the study. Patients who presented with NVUGIH, or who were diagnosed with the disease (by endoscopy examination) between January 1, 2008, and December 31, 2012 were included in this study. The inclusion criteria were the following:
1. NVUGIH defined as hematemesis, melena, coffee grounds vomiting, fresh blood vomiting or positive fecal occult blood test; 2. bleeding unrelated to varices as confirmed by endoscopy.
Patients < 18 years old and those with primary diagnoses other than NVUGIH were excluded from the study.
The diagnosis of NVUGIH was based on International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes.
Treatment
All patients underwent a gastrointestinal endoscopy after hospital admission. During this study, all patients received a combination of proton pump inhibitors, and fluid resuscitation that secured airway and breathing. The updated British Society of Gastroenterology guidelines were followed for general management. [12] 2.3. Data collection Data collection was performed at each medical center using a standard table with an electronic medical record system. For each participant, the following information were collected: gender, age, history of upper gastrointestinal bleeding, syncope, cardiac failure or liver disease, number of hospitalization days, hospitalization costs, clinical symptoms, blood pressure, heart rate, laboratory parameters, endoscopic diagnosis, Forrest classification, treatment and outcome data in the form of interventions (bleeding, the needs for further surgery, endoscopic intervention) or death, etc. The data entry was controlled by 2-pass verification of all collected data to ensure the quality of the data.
Analysis of GBS and pre-endoscopic RS
The pre-endoscopic RS, CRS [3] ( Table 1) and GBS [4] ( Table 2) were calculated based on patients pre-endoscopic and endoscopic variables.
Statistical analysis
SPSS software (version 17.0, SPSS, Chicago, IL) was used for all statistical analyses in this study. The clinical demographic and epidemiologic features were analyzed using a descriptive statistical method (mean ± standard deviation, percentage, median, and interquartile range). Between-group comparisons of normally distributed data were performed using Student's t test. Data with non-normal distribution were compared using ranksum tests. Count data were compared using chi-square tests. Comparisons between the scores for separate death outcomes, endoscopic or surgical therapy were made by calculating the areas under the receiver-operator characteristic (ROC) curves with 95% CI. Accuracy was tested by calculating the area under the curve (AUC) of the ROC curve, where AUC ≥ 0.70 indicated that the scoring system had good accuracy. The AUCs were compared using Z tests. A P value < 0.05 was considered statistically significant.
Results
A total of 2977 patients with NVUGIH were included in the study. The mean age of patients was 54.65± 14.34 years, the ratio of men to women was 3.25:1, and the mean hospitalization duration was 9.48± 8.4 days. Among all patients, 19.65% (585/2977) underwent emergency endoscopy and the median time from gastrointestinal bleeding to gastroscopy was 72 hours (36-120 hours), and 23.45% (698/2977) received a transfusion of red blood cell suspensions. A total of 19.08% (568/2977) of patients had high-risk peptic ulcer bleeding. A total of 5.34% (159/2977) underwent endoscopic therapy, with a treatment rate of 16.9% in high-risk peptic ulcer patients (96/568) ( Table 1) . Patients were scored using the CRS and GBS criteria, followed by risk stratification. Based on the Rockall score, 1780 patients were at low risk, 927 at moderate risk, and 270 at high risk (Table S1 , http://links.lww.com/MD/C997, Table S2 , http://links.lww.com/MD/C997), based on the Blatchford scores, 414 patients were at low-risk and 2123 at high-risk (Table S3 , http://links.lww.com/MD/C997, Table S4 , http://links.lww.com/ MD/C997).
When adjusting for age, ward type and Rockall, the odds ratio of death for pre-endoscope RS was 1.745 (95%CI: 1.493-2.041). Moreover, when adjusting for age, re-bleeding and ward type, the odds ratio of death for CRS was 1.802 (95%CI: 1.479-2.196). Interestingly, when adjusting for age, heart rate, hemoglobin, comorbidities, surgery, re-bleeding and ward type, the death odds ratio for GBS was 1.106 (95%CI: 1.007-1.216) ( Table 2) . ROC curves were plotted for the 3 scoring systems with reference to their prediction of mortality, rebleeding, and need for surgery ( Table 3 ). The AUCs for the pre-endoscopic RS, CRS, and GBS to predict mortality were 0.842 (95%CI: 0.827-0.855), 0.804 (95% CI: 0.788-0.818), and 0.622 (95% CI: 0.603-0.640), respectively (Fig. 1) .
The AUCs for the pre-endoscopic RS, CRS, and GBS to predict rebleeding were 0.658 (95% CI: 0.640-0.676), 0.548 (95% CI: 0.529-0.566), and 0.528 (95% CI: 0.509-0.546), respectively (Fig. 2) .
The AUCs for the pre-endoscopic RS, CRS, and GBS in predicting the need for surgery were 0.589 (95% CI: 0.571- Diagnostic value of different scoring system for predicting mortality, surgical therapy or re-bleeding. 
Discussion
The GBS and RS are widely used for stratifying NVUGIH cases in terms of risk. Nevertheless, their clinical effectiveness remains unclear, and there is little evidence available for Asian population. The aim of the present study was to verify the efficiency and accuracy of these 2 scoring systems in clinical application in Chinese patients. In this study, we collectively analyzed the clinical outcomes in 2977 individuals with NVUGIH according to GBS and RS scoring systems. Among the 2977 patients, the pre-endoscopic RS and CRS were superior to the GBS score (P < .01) in predicting mortality. The preendoscopic RS predicting re-bleeding was better than the CRS and the GBS score (P < .01). Nonetheless, these 3 scoring systems were poor predictors of surgical operation ability (AUC: 0.589 vs 0.547 vs 0.504, respectively). Our data collectively demonstrated that the GBS and RS systems could be used to predict clinical outcomes in nonvariceal upper gastrointestinal bleeding. NVUGIH is an acute, severe condition that can lead to serious consequences. The RS and GBS scoring systems, are currently used in clinical settings for stratifying the risk of NVUGIH where RS is the more popular one. [13] In 2010, the International Consensus on NVUGIH clearly identified the risk assessment methods for such patients. [2] In 2011, [14] the Asia-Pacific Working Group consensus on NVUGIH formulated NVUGIH treatment guidelines that were adapted to Asian population based on the actual conditions of people in the Asia-Pacific region (e.g., economic level and drug metabolism), while also collating research related to NVUGIH risk assessment in the Asia-Pacific region. [15] Unfortunately, there is a lack of large-sample randomized controlled trials that would provide a higher level of evidence.
The pre-endoscopic RS and CRS revealed positive predictive value for mortality, which was consistent with the study results reported by Dicu et al [16] The prediction ability for re-bleeding was significantly higher in pre-endoscopic RS, compared with the CRS. Nevertheless, its predictive value for the need for surgery was poor. Lima and colleagues [17] have also shown that the RS could not predict surgery or endoscopic intervention and rebleeding, while it could predict the value for mortality. A study conducted at Beijing Xuanwu Hospital in geriatric patients has indicated that the scoring system has good predictive value for mortality, re-bleeding, and surgery. Yet, Lima and his team [17] have shown that the pre-endoscopic RS unsatisfactorily predicts endoscopic intervention, re-bleeding, and death. It is important to note that, in our study, 1771 patients were <60 years old, 999 were 60 to 79 years old, and 207 were ≥80 years old, and patients ≥60 years accounted for 40.5% of the study population. In the study by Dicu et al, patients above 70 years accounted for 33% of the total population, and thus the observed differences might be related to the age of the research subjects.
The GBS scoring system, [4, 18, 19] is used during outpatient treatment or upon admission to the hospital to determine whether patients can receive outpatient treatment or treatment with early discharge within 24 hours. Its clinical advantage is that patients with Blatchford score of 0 points can be categorized as low risk, which results in saving medical resources. [20] In the present study, the predictive value of GBS scoring system for mortality, rebleeding, and surgery was not satisfactory. Yet, Bryant et al [21] did not prove that the predictive value of the Blatchford score with reference to the need for inpatient transfusion and surgery is superior to the CRS. The predictive values for endoscopic intervention, re-bleeding, and mortality differed from our research results, which might be due to the inclusion of patients with variceal upper gastrointestinal bleeding. A recent study [22] has indicated that GBS performs has relatively good performance in prediction of the need for clinical interventions (endoscopic intervention, angiographic embolization, and surgery) in patients with cancer.
Our comparison of the 3 scoring systems revealed that the preendoscopic RS and CRS were both superior to the GBS in their prediction of mortality. The pre-endoscopic RS was better at predicting re-bleeding than the CRS and GBS. All 3 scoring systems had poor efficiency power in predicting the need for surgery. Nonetheless, in high-risk patients with peptic ulcer bleeding, the RS has better predictive power for 30-day mortality Medicine than the GBS. [23] In addition, the GBS does not have the predictive value for endoscopic intervention. [24] A retrospective study [25] has shown that the mortality rates of high-risk patients with GBS >12 points could be reduced if these patients underwent endoscopic examination within 13 hours. Therefore, endoscopic examination should be performed as soon as possible in patients with a GBS >12 points. [20] This study has some limitations that have to be pointed out: first, this is a retrospective study, which means that compared to the randomized case control studies the evidence level is limited. Moreover, the record of clinical outcomes is limited to the events that happened during the stay at hospital, which could cause bias. However, all patients were followed up for relevant severe outcomes, which in our opinion should not devalue the main findings reported in this article.
Our results showed that the Blatchford and Rockall scoring systems can be used for prediction of clinical outcomes in nonvariceal upper gastrointestinal bleeding, which is consistent with previous reports. The application of the GBS scoring system in emergency and cancer patients has been constantly validated, and future studies should further refine the scope of the scoring system for clinical application. In addition, more high-quality clinical trials are required for further verification.
